Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 86 days ( -49.25 % )
Last Price $1.00 0 %
High/ Low $1.00 - $1.00 0%
Chg 7 Days N/A $1.00 $1.00
Chg 30 Days N/A $1.00 $1.00
Chg 12 mos -1.96 % $1.02 $1.00
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -0.321 % Width: 156.36 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $0.477 - $1.22 -52.32 % - 22.22 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Apr 12, 2023 - 99 days
Long MA avg 12 mos Buy May 03, 2023 - 84 days
Short/Long MA avg 12 mos Buy May 05, 2023 - 82 days
Pivot Short Sell Aug 29, 2023 - 3 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Angion Biomedica Corp.

Angion Biomedica . Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute ... ANGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT